EN
LOGIN
REGISTER
×
Logging off
All data generated by the account on the platform will be deleted after logout.
Cancer Biology & Medicine
ISSN 2095-3941
CN 12-1431/R
Editor-in-Chief: Xishan Hao
Open Access
Journal Home
Articles & Issues
Articles & Issues
Latest Issue
All Issues
×
New Search
Advanced Search
Journal Alert
Cancer Biology & Medicine
Alert type: Latest Issue
Frequency:
As published
Alert type: Online First
Frequency:
Month
Week
Day
RSS feed for
Cancer Biology & Medicine
Paste the URL in your RSS reader:
https://www.sciopen.com/journal/rss/2095-3941
Link copied
复制
About This Journal
About Journal
Editorial Board
Editorial Office
Publishing Ethics
Copyright & Permission
Abstracting & Indexing
For Authors
Submission Guidelines
Submit Manuscript
Recommended Articles
No data available
Latest Issue
All Issues
View All
Most Downloaded
Most Cited
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
Chun Wang, Qiushi Li, Jian Xiao, Yang Liu
Review
Published: 05 June 2023
Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang, Qianghu Wang
Perspective
Published: 05 June 2023
Expert opinion on translational research for advanced glioblastoma treatment
Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang, Chunsheng Kang
Review
Published: 05 June 2023
Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu, Qixue Wang
Original Article
Published: 05 June 2023
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
Yingyan Yu, Wenjie Peng
Review
Published: 05 June 2023
Development of glioblastoma organoids and their applications in personalized therapy
Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang, Yanli Tan
Review
Published: 05 June 2023
Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
Junhu Zhou, Fei Tong, Jixing Zhao, Xiaoteng Cui, Yunfei Wang, Guangxiu Wang, Chunsheng Kang, Xiaomin Liu, Qixue Wang
Original Article
Published: 05 June 2023
Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang, Qianghu Wang
Perspective
Published: 05 June 2023
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas
Chun Wang, Qiushi Li, Jian Xiao, Yang Liu
Review
Published: 05 June 2023
Development of glioblastoma organoids and their applications in personalized therapy
Can Xu, Xiaoye Yuan, Pengyu Hou, Ziru Li, Changsheng Wang, Chuan Fang, Yanli Tan
Review
Published: 05 June 2023
Expert opinion on translational research for advanced glioblastoma treatment
Xiaoteng Cui, Yunfei Wang, Junhu Zhou, Qixue Wang, Chunsheng Kang
Review
Published: 05 June 2023
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy
Yingyan Yu, Wenjie Peng
Review
Published: 05 June 2023
View All
View All
Select Folder
Create new folder
Delete folder
Cite this article(RIS)
Top